Skip to content
Armstrong Clinical
  • Home
  • Company
    • Why Us?
    • Our People
    • Our Workflow
    • Join our Team
  • Services
    • Clinical Development: Path to Market
    • AI-Powered Clinical Study Designs
    • Study Locations and Site Identification
    • CRO Selection and Study Oversight
  • Blog
  • Contact
  • Request for Proposal
  • Toggle website search
Press Escape to close the search panel.
  • Home
  • Company
    • Why Us?
    • Our People
    • Our Workflow
    • Join our Team
  • Services
    • Clinical Development: Path to Market
    • AI-Powered Clinical Study Designs
    • Study Locations and Site Identification
    • CRO Selection and Study Oversight
  • Blog
  • Contact
  • Request for Proposal
  • Toggle website search
Search this website

Blog

  2. Tag
  3. Regulatory
Read more about the article White Paper: EMA’s 2017 FIH Guidelines. 5 years on and the Impact on Early Phase Clinical Studies
  • Post category:Clinical Development

White Paper: EMA’s 2017 FIH Guidelines. 5 years on and the Impact on Early Phase Clinical Studies

AC-Impact-of-EMAs-guidelines-on-FIH-studies-2022-White-Paper-Download

Armstrong Clinical Logo

Based in Melbourne, Australia, Armstrong Clinical is an experienced and reliable clinical development consulting company

Quick Links

  • Home
  • Company
  • Services
  • Blog
  • Request for Proposal
  • Contact

Services

  • Clinical Development
  • AI-Powered Clinical Study Designs
  • Study Locations and Site Identification
  • CRO Selection and Study Oversight

Recent Posts

  • White Paper: EMA’s 2017 FIH Guidelines. 5 years on and the Impact on Early Phase Clinical Studies
    White Paper: EMA’s 2017 FIH Guidelines. 5 years on and the Impact on Early Phase Clinical Studies
    October 19, 2022/
    0 Comments
  • AC Celebration our First 2 Years
    AC Celebration our First 2 Years
    July 23, 2021/
    0 Comments
  • Our Blog

Armstrong Clinical © 2026 All Rights Reserved • Website by Uplift 360